Login / Signup

Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.

Soumyajit RoyTahmineh RomeroJeff M MichalskiFelix Y FengJason Alexander EfstathiouColleen A F LawtonMichel BollaPhilippe MaingonTheo de ReijkeDavid JosephWee Loon OngMatthew R SydesDavid P DearnaleyAlison C TreeNathalie CarrierAbdenour NabidLuis SouhamiLuca IncrocciWilma D HeemsbergenFloris J PosAlmudena ZapateroAraceli GuerreroAna AlvarezCarmen Gonzalez San-SegundoXavier MaldonadoRobert E ReiterMatthew B RettigNicholas G NickolsMichael L SteinbergLuca F ValleTing Martin MaMatthew J FarrellBeth K NeilsenJesus E JuarezJie DengSitaram VangalaNorbert AvrilAngela Y JiaNicholas G ZaorskyYilun SunDaniel E SprattAmar U Kishannull null
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
BCRFS and TTBCR are prognostic but failed to satisfy all surrogacy criteria. Strength of correlation was greater when noncancer-related deaths were considered events.
Keyphrases
  • locally advanced
  • prostate cancer
  • early stage
  • squamous cell carcinoma
  • radiation therapy
  • radiation induced
  • benign prostatic hyperplasia
  • rectal cancer